Search
Menu
DataRay Inc. - ISO 11146-Compliant Laser Beam Profilers

Biomolecular Characterization Device

RedShift BioAnalytics Inc.Request Info
 
Facebook X LinkedIn Email
BURLINGTON, Mass., May 17, 2022 — Biomolecular Characterization DeviceThe Apollo biomolecular characterization device from RedShift BioAnalytics Inc. uses microfluidic modulation spectroscopy (MMS) technology to provide sensitive, precise measurements of biomolecule structures.

Users are able to compare higher-order structure and similarity profiles for confidence in structural similarity and activity to inform discovery, screening, formulation, and quality control in biopharmaceutical drug development. The device provides accurate and reproducible measurements with a broad concentration range from 0.1 mg/ml to >200 mg/ml, allowing measurement in native conditions.



Published: May 2022
REQUEST INFO ABOUT THIS PRODUCT
* First Name:
* Last Name:
* Email Address:
* Company:
* Country:
Message:


When you click "Send Request", we will record and send your personal contact information to RedShift BioAnalytics Inc. by email so they may respond directly. You also agree that Photonics Media may contact you with information related to this inquiry, and that you have read and accept our Privacy Policy and Terms and Conditions of Use.

Register or login to auto-populate this form:
Login Register
* Required

ProductsApollobiomolecular characterization deviceRedshift BioanalyticsTest & MeasurementspectroscopyBiophotonicsR&DmedicinemedicalAmericas

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.